| Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload. | |
| | |
MedLine Citation:
|
PMID: 20562336 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Adenylyl cyclase (AC) type 5 (AC5) and AC type 6 (AC6) are the two major AC isoforms in the heart. Cardiac overexpression of AC6 has been shown to be protective in response to several interventions. In this investigation, we examined the effects of chronic pressure overload in AC6 transgenic (TG) mice. In the absence of any stress, AC6 TG mice exhibited enhanced contractile function compared with their wild-type (WT) littermates, i.e., increased (P < 0.05) left ventricular (LV) ejection fraction (EF) (75 +/- 0.9 vs. 71 +/- 0.5%) and LV dP/dt (7,850 +/- 526 vs. 6,374 +/- 315 mmHg/s). Forskolin (25 microg x kg(-1) x min(-1) for 5 min) increased LVEF more (P < 0.05) in AC6 TG mice (14.8 +/- 1.0%) than in WT mice (7.7 +/- 1.0%). Also, isoproterenol (0.04 microg x kg(-1) x min(-1) for 5 min) increased LVEF more (P < 0.05) in AC6 TG mice (18.0 +/- 1.2%) than in WT mice (11.6 +/- 2.1%). Pressure overload, induced by 4 wk of transverse aortic constriction (TAC), increased the LV weight-to-body weight ratio and myocyte cross-sectional area similarly in both groups, but reduced LVEF more in AC6 TG mice (22%) compared with WT mice (9%), despite the higher starting level of LVEF in AC6 TG mice. LV systolic wall stress increased more in AC6 TG mice than in WT mice, which could be responsible for the reduced LVEF in AC6 TG mice with chronic pressure overload. In addition, LV dP/dt was no longer elevated in AC6 TG mice after TAC compared with WT mice. LV end-diastolic diameter was also greater (P < 0.05) in AC6 TG mice (3.8 +/- 0.07 mm) than in WT mice (3.6 +/- 0.05 mm) after TAC. Thus, in contrast to other interventions previously reported to be salutary with cardiac AC6 overpression, the response to chronic pressure overload was not; actually, AC6 TG mice fared worse than WT mice. The mechanism may be due to the increased LV systolic wall stress in AC6 TG mice with chronic pressure overload. |
| | |
Authors:
|
Aziz Guellich; Shumin Gao; Chull Hong; Lin Yan; Thomas E Wagner; Sunil K Dhar; Bijan Ghaleh; Luc Hittinger; Kosaku Iwatsubo; Yoshihiro Ishikawa; Stephen F Vatner; Dorothy E Vatner |
Related Documents
:
|
9619616 - Assessment of left ventricular systolic wall motion velocity with pulsed tissue doppler... 15155526 - Effect of cardiac myosin binding protein-c on mechanoenergetics in mouse myocardium. 9141376 - Hemodynamic effects of fructose 1,6-diphosphate in patients with normal and impaired le... 6527976 - Effects of nicardipine or nifedipine added to propranolol in patients with coronary art... 8123766 - An algorithm establishing a defined ergometric cardiovascular load. 11668046 - Vagal cardiac function and arterial blood pressure stability. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2010-06-18 |
Journal Detail:
|
Title: American journal of physiology. Heart and circulatory physiology Volume: 299 ISSN: 1522-1539 ISO Abbreviation: Am. J. Physiol. Heart Circ. Physiol. Publication Date: 2010 Sep |
Date Detail:
|
Created Date: 2010-08-31 Completed Date: 2010-09-22 Revised Date: 2011-09-13 |
Medline Journal Info:
|
Nlm Unique ID: 100901228 Medline TA: Am J Physiol Heart Circ Physiol Country: United States |
Other Details:
|
Languages: eng Pagination: H707-12 Citation Subset: IM |
Affiliation:
|
Department of Cell Biology and Molecular Medicine and Cardiovascular Research Institute, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adenylate Cyclase
/
genetics,
metabolism* Analysis of Variance Animals Apoptosis / drug effects, physiology Echocardiography Forskolin / pharmacology Heart / drug effects, physiopathology* Heart Rate / drug effects, physiology Heart Ventricles / drug effects, metabolism*, physiopathology Hemodynamics Hypertrophy, Left Ventricular / metabolism*, physiopathology Isoproterenol Mice Mice, Transgenic Myocardial Contraction / drug effects, physiology Myocardium / metabolism* Stress, Physiological / physiology Ventricular Dysfunction, Left / metabolism*, physiopathology |
| Grant Support | |
ID/Acronym/Agency:
|
AG-014121/AG/NIA NIH HHS; AG-023137/AG/NIA NIH HHS; AG-027211/AG/NIA NIH HHS; HL-033107/HL/NHLBI NIH HHS; HL-059139/HL/NHLBI NIH HHS; HL-069020/HL/NHLBI NIH HHS; HL-069752/HL/NHLBI NIH HHS; HL-095888/HL/NHLBI NIH HHS; R01 HL033107-27/HL/NHLBI NIH HHS; R01 HL093481-03/HL/NHLBI NIH HHS; R01 HL095888-03/HL/NHLBI NIH HHS; R01 HL102472-02/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
66428-89-5/Forskolin; 7683-59-2/Isoproterenol; EC 4.6.1.1/Adenylate Cyclase; EC 4.6.1.1/adenylyl cyclase 6 |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Wave intensity analysis of right ventricular and pulmonary vascular contributions to higher pulmonar...
Next Document: H2O2 alters rat cardiac sarcomere function and protein phosphorylation through redox signaling.